Fresenius Kabi USA LLC is recalling approximately 234,800 vials of Xylocaine-MPF with Epinephrine 1:200,000 (Lidocaine HCl and Epinephrine Injection, USP), 1%, in 30 mL single-dose vials. The recall was initiated because laboratory testing revealed lower-than-required levels of epinephrine in certain batches. This product is typically used as a local anesthetic for surgical procedures, and if the epinephrine levels are too low, the medication may not work as intended. Consumers and healthcare providers should check for specific lot numbers and contact their pharmacist or healthcare provider for guidance on returning the product for a refund.
Epinephrine is added to lidocaine to help control bleeding and to make the anesthetic effect last longer by narrowing blood vessels. If levels are lower than specified, the medication may wear off too quickly or fail to control local bleeding during a medical procedure, potentially requiring additional medical intervention.
Healthcare provider or pharmacy refund
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.